title: Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.
authors.affiliation: Department of Internal Medicine, Medstar Georgetown University Hospital, Washington, DC, USA.
authors.forename: Katherine J
authors.initials: KJ
authors.lastname: Hahn
authors.affiliation: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Nancy
authors.initials: N
authors.lastname: Ho
authors.affiliation: Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Lynne
authors.initials: L
authors.lastname: Yockey
authors.affiliation: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Samantha
authors.initials: S
authors.lastname: Kreuzberg
authors.affiliation: Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Janine
authors.initials: J
authors.lastname: Daub
authors.affiliation: Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Rump
authors.affiliation: Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Beatriz E
authors.initials: BE
authors.lastname: Marciano
authors.affiliation: National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Martha
authors.initials: M
authors.lastname: Quezado
authors.affiliation: Laboratory of Host Defense (LHD), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Harry L
authors.initials: HL
authors.lastname: Malech
authors.affiliation: Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Holland
authors.affiliation: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Theo
authors.initials: T
authors.lastname: Heller
authors.affiliation: Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Christa S
authors.initials: CS
authors.lastname: Zerbe
mesh_terms: D000293:Adolescent; D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002648:Child; D003092:Colitis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006105:Granulomatous Disease, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D060046:Maintenance Chemotherapy; D008297:Male; D012074:Remission Induction; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein